Michael Wantman

775 total citations
11 papers, 540 citations indexed

About

Michael Wantman is a scholar working on Infectious Diseases, Virology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Wantman has authored 11 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Virology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Wantman's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Michael Wantman is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Michael Wantman collaborates with scholars based in United States, Sweden and Switzerland. Michael Wantman's co-authors include James H. Warram, L Hanna, Andrzej S. Królewski, Anne Zanchi, Dariusz Moczulski, A S Krolewski, Scott M. Hammer, Damian Fogarty, John W. Mellors and Laura J. Scott and has published in prestigious journals such as Diabetes, Kidney International and Journal of Clinical Microbiology.

In The Last Decade

Michael Wantman

11 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Wantman United States	10	200	200	128	123	113	11	540
J. Röling Germany	3	37 0.2×	139 0.7×	115 0.9×	24 0.2×	93 0.8×	3	362
Stefania Mazza Italy	12	80 0.4×	16 0.1×	77 0.6×	72 0.6×	143 1.3×	18	642
Sarah L. Fishman United States	7	33 0.2×	46 0.2×	66 0.5×	18 0.1×	109 1.0×	12	581
Meghan N. Feldpausch United States	13	75 0.4×	77 0.4×	120 0.9×	7 0.1×	212 1.9×	30	599
Jordi P Guallar Spain	7	142 0.7×	163 0.8×	18 0.1×	9 0.1×	17 0.2×	9	391
Josef van Helden Germany	15	48 0.2×	81 0.4×	25 0.2×	18 0.1×	90 0.8×	43	557
Samuel Orden Spain	13	45 0.2×	88 0.4×	33 0.3×	7 0.1×	23 0.2×	16	402
Gabriella Di Lorenzo Italy	12	85 0.4×	144 0.7×	94 0.7×	3 0.0×	22 0.2×	14	751
Tomika Ludaway United States	12	95 0.5×	162 0.8×	48 0.4×	8 0.1×	10 0.1×	15	543
Paola Mancino Italy	14	46 0.2×	59 0.3×	35 0.3×	13 0.1×	38 0.3×	26	490

Countries citing papers authored by Michael Wantman

Since Specialization

Citations

This map shows the geographic impact of Michael Wantman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wantman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wantman more than expected).

Fields of papers citing papers by Michael Wantman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wantman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wantman. The network helps show where Michael Wantman may publish in the future.

Co-authorship network of co-authors of Michael Wantman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wantman. A scholar is included among the top collaborators of Michael Wantman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wantman. Michael Wantman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Halvas, Elias K., Ann Wiegand, Valerie F. Boltz, et al.. (2010). Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients. The Journal of Infectious Diseases. 201(5). 1818331743–0. 81 indexed citations

2.

Benson, Constance A., Florin Vaida, Diane V. Havlir, et al.. (2006). A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug‐Resistant HIV: 48‐Week Virologic Results of ACTG A5086. The Journal of Infectious Diseases. 194(9). 1309–1318. 18 indexed citations

3.

Dykes, Carrie, Ronald J. Bosch, Michael Wantman, et al.. (2004). Detection of Drug‐Resistant Minority Variants of HIV‐1 During Virologic Failure of Indinavir, Lamivudine, and Zidovudine. The Journal of Infectious Diseases. 189(6). 1091–1096. 23 indexed citations

4.

Krogstad, Paul, Susan H. Eshleman, Yongzhi Geng, et al.. (2002). Mother-to-Child Transmission in the United States of Subtypes D and A/G Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 18(6). 413–417. 9 indexed citations

5.

Eshleman, Susan H., Paul Krogstad, J. Brooks Jackson, et al.. (2001). Analysis of Human Immunodeficiency Virus Type 1 Drug Resistance in Children Receiving Nucleoside Analogue Reverse‐Transcriptase Inhibitors plus Nevirapine, Nelfinavir, or Ritonavir (Pediatric AIDS Clinical Trials Group 377). The Journal of Infectious Diseases. 183(12). 1732–1738. 38 indexed citations

6.

Cunningham, Shawn, Bonnie J. Ank, Wei Lü, et al.. (2001). Performance of the Applied Biosystems ViroSeq Human Immunodeficiency Virus Type 1 (HIV-1) Genotyping System for Sequence-Based Analysis of HIV-1 in Pediatric Plasma Samples. Journal of Clinical Microbiology. 39(4). 1254–1257. 36 indexed citations

7.

Zanchi, Anne, Dariusz Moczulski, L Hanna, et al.. (2000). Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International. 57(2). 405–413. 13 indexed citations

8.

Zanchi, Anne, Dariusz Moczulski, L Hanna, et al.. (2000). Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International. 57(2). 405–413. 167 indexed citations

9.

Fogarty, Damian, L Hanna, Michael Wantman, et al.. (2000). Segregation analysis of urinary albumin excretion in families with type 2 diabetes.. Diabetes. 49(6). 1057–1063. 52 indexed citations

10.

Warram, James H., Laura J. Scott, L Hanna, et al.. (2000). Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia.. Diabetes. 49(1). 94–100. 74 indexed citations

11.

Małecki, Maciej T., Anthony Antonellis, Linong Ji, et al.. (1998). Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.. Diabetes. 47(6). 970–972. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact